API - Aplicaciones para la Industria

New technologies have come to make life easier for us in many ways, especially in industries and companies in different sectors. One of the main ones is automation, either through robotics or advanced and easy software, adapted to the different needs of each company. As this continues to advance, we…

Affecting 10 percent of the global population and responsible for more than a million deaths each year, chronic kidney disease (CKD) has become a major public health issue1. In the U.S. alone 30 million people, or 15 percent of adults, are estimated to have chronic kidney disease2. Around the world,…

Fully automated chemistry, specialty, immunoassay and integrated platforms deliver powerful productivity and efficiency ADVIA Centaur® Systems ADVIA® Chemistry Systems IMMULITE® Systems BN ProSpec®/BNII™ Systems Dimension® System VersaCell® Automation systems Via helathcare.siemens.com.mx

More than 220 million people worldwide have diabetes, and this number is likely to more than double by 2030 without intervention.1 In the US, diabetes is the seventh leading cause of death, and recent surveys estimate that the annual costs associated with the chronic care of the complications of diabetes…

More than 200 million people worldwide suffer from diabetes1. Of these, 20-30% will develop kidney disease, which is the most common complication of diabetes2. In early stages of kidney disease, early detection is key since there are typically no signs or symptoms and the disease is treatable and reversible.3 Cystatin…

Reducing the burden of breast cancer in women includes: Understanding risk factors Making rapid, accurate diagnoses when symptoms occur Implementing appropriate therapies Monitoring treatment Laboratory diagnostic testing plays an integral role in caring for women with breast cancer. Siemens’ comprehensive solutions follow the complete continuum of care for breast cancer,…

Breast cancer causes more than 450,000 deaths each year. It is the most commonly diagnosed cancer in women and the second-leading cause of cancer death among women. If detected early, when the cancer is localized in the breast, five-year survival statistics are approximately 98%. 1.4 million women globally are diagnosed…